Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

17.17
Delayed Data
As of 4:00pm ET
 -0.02 / -0.12%
Today’s Change
15.22
Today|||52-Week Range
51.15
-52.63%
Year-to-Date

Today’s Trading

Previous close17.19
Today’s open17.23
Day’s range17.07 - 17.42
Volume9,895,915
Average volume (3 months)17,106,391
Market cap$17.4B
Dividend yield6.44%
Data as of 4:00pm ET, 09/25/2017

Growth & Valuation

Earnings growth (last year)-96.18%
Earnings growth (this year)-16.10%
Earnings growth (next 5 years)-0.15%
Revenue growth (last year)+12.01%
P/E ratioNM
Price/Sales1.59
Price/Book0.59

Competitors

 Today’s
change
Today’s
% change
BGNEBeiGene Ltd+0.12+0.14%
TYMETyme Technologies In...-0.14-2.63%
OASMOasmia Pharmaceutica...-0.02-1.96%
Data as of 4:00pm ET, 09/25/2017

Financials

Next reporting dateNovember 2, 2017
EPS forecast (this quarter)$1.08
Annual revenue (last year)$22.0B
Annual profit (last year)$330.0M
Net profit margin1.50%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President &
Chief Executive Officer
Kåre Schultz
President &
CEO-Global Operations
Carlo de Notaristefani
Corporate headquarters
Petach Tikva, Hamerkaz

Forecasts